ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

HCC and Liver Transplantation Following the Recent Allocation Policy Change.

T. Ishaque, A. Massie, M. Bowring, J. Ruck, A. Cameron, B. Philosophe, D. Segev.

Johns Hopkins University, Baltimore

Meeting: 2017 American Transplant Congress

Abstract number: 204

Keywords: Hepatocellular carcinoma, Mortality, Waiting lists

Session Information

Session Name: Joint Plenary Session II

Session Type: Plenary Session

Date: Monday, May 1, 2017

Session Time: 8:30am-9:30am

 Presentation Time: 9:15am-9:30am

Location: Arie Crown Theater

In October 2015, OPTN implemented a revised liver allocation policy to address the disparity between HCC and non-HCC patients in access to deceased-donor liver transplant (DDLT). Under the new policy, HCC patients obtain exception points only after 6 months on the waitlist. The impact of this policy change on access to DDLT for HCC and non-HCC patients has not been described.

Methods: Using SRTR data on 30,689 adult, first-time, active DDLT waitlist registrants 2007-2016, we compared access to DDLT and mortality risk in HCC vs. non-HCC patients, pre-implementation (10/8/2014-10/7/2015) and post-implementation (10/8/2015-5/31/2016). We used Cox regression to model cause-specific hazard, and Fine and Gray methods to model mortality accounting for the competing risk of transplantation, adjusting for age, gender, race, and initial biological MELD. Waitlist dropout due to deteriorating condition was classified as mortality.

Results: Pre-implementation, HCC patients had 3-fold higher access to DDLT than non-HCC patients (aHR= 2.84 3.07 3.33) but also had an increased risk of death/dropout (aHR= 1.47 1.72 2.01). After accounting for the reduction in mortality in both groups due to transplant, HCC and non-HCC patients had a comparable chance of experiencing waitlist death/dropout (asHR= 0.92 1.08 1.26). Post-implementation, HCC patients still had greater access to DDLT, but the association was attenuated to a 2-fold difference (aHR= 1.76 1.96 2.18). After accounting for the reduction in mortality in both groups due to transplant, HCC patients and non-HCC patients continued to have a comparable chance of waitlist death/dropout (asHR= 0.67 0.85 1.07) [table 1].

Conclusion: The HCC allocation policy change reduced the disparity in access to DDLT between HCC and non-HCC patients with no increase in relative waitlist mortality for HCC patients.

CITATION INFORMATION: Ishaque T, Massie A, Bowring M, Ruck J, Cameron A, Philosophe B, Segev D. HCC and Liver Transplantation Following the Recent Allocation Policy Change. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Ishaque T, Massie A, Bowring M, Ruck J, Cameron A, Philosophe B, Segev D. HCC and Liver Transplantation Following the Recent Allocation Policy Change. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/hcc-and-liver-transplantation-following-the-recent-allocation-policy-change/. Accessed May 11, 2025.

« Back to 2017 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences